Cargando…
Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report
Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. As a breakthrough against infection, vaccines have been developed to achieve herd immunity. Here, we report the first case of microscopic polyangiitis (MPA) following BNT162b2 vaccination in Korea. A...
Autores principales: | So, Daeyoung, Min, Kyueng-Whan, Jung, Woon Yong, Han, Sang-Woong, Yu, Mi-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110267/ https://www.ncbi.nlm.nih.gov/pubmed/35578586 http://dx.doi.org/10.3346/jkms.2022.37.e154 |
Ejemplares similares
-
mRNA-1273: Microscopic polyangiitis: case report
Publicado: (2021) -
De Novo and Relapsing Glomerulonephritis following SARS-CoV-2 mRNA Vaccination in Microscopic Polyangiitis
por: Davidovic, Tamara, et al.
Publicado: (2021) -
Cardiac Tamponade as a Complication of Microscopic Polyangiitis: A Case Associated With a COVID-19 mRNA Vaccine
por: Avalos, Cesar, et al.
Publicado: (2023) -
New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
por: Nappi, Emanuele, et al.
Publicado: (2022) -
The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
por: Pyo, Jung Yoon, et al.
Publicado: (2021)